VALE S.A. American Depositary Shares Each Representing one common share (VALE)
StalwartFairStock Score: 51/100 — MIXED
Key Financials
| Current Price | $16.32 |
| Market Cap | $73.1B |
| P/E Ratio | 24.73 |
| ROE | 6.84% |
| Dividend Yield | 8.26% |
| Sector | Basic Materials |
Strengths
- Generates $15.4 billion in annual free cash flow (21.1% yield on market cap)
- Attractive 7.2% dividend yield providing steady income returns
- Established organization with 65,805 employees providing operational scale
Concerns
- Trades significantly above Graham Number ($10) with negative 74% margin of safety—limited downside protection
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Altman Z-Score of 1.1 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
VALE S.A. American Depositary Shares Each Representing one common share is a large-cap basic materials company valued at $73.1 billion. Revenue stands at $213.6 billion, though the company is currently unprofitable. From a quality standpoint, VALE shows distressed Altman Z-Score of 1.1 warrants caution and modest 6% ROE. On valuation, the stock is trading at a premium 31.2x earnings, with trades above its Graham Number with a negative 74% margin. Growth dynamics show revenue growing at 9.3% and profit growth of -453.9%. The 7.2% dividend yield adds an income component for patient holders. Our composite FairStock Score of 51/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $15.4 billion in annual free cash flow (21.1% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
At 31x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer